Andrea Rossi
Group Leader
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Andrea Rossi is the Head at IUF - Leibniz-Institut für umwelt-medizinische Forschung gGmbH in Germany. His research focuses on the effects of environmental toxins on microbial glycosylation, stem cell biology, and RNA editing technologies. Recent publications include studies on induced pluripotent stem cells and their applications in neuroscience and metabolic disorders.
Positions (1)
Andrea Rossi
Leibniz Research Institute for Environmental Medicine (IUF)
PhD position available for a joint project between the Environmental Adaptation & Cellular Resilience Lab at the Leibniz Research Institute for Environmental Medicine (IUF) and Prof. Alessandro Prigione’s lab at Heinrich Heine University Düsseldorf / University Hospital Düsseldorf . The DFG-funded project will study mitochondrial DNA heteroplasmy during the reprogramming of human cells into iPSCs and their differentiation into neurons . The research combines human iPSC models , neuronal differentiation , organoids , long-read mtDNA sequencing , bioinformatics , genome editing , and small-molecule screening . Location: Düsseldorf, Germany. Start: ideally 1 October 2026. Duration: 3 years. Funding: TV-L E13, 65%. Applicants should hold a relevant Master’s degree and have hands-on experience in mammalian cell culture . Experience with iPSCs , neuronal differentiation , organoids , genome engineering , mitochondrial biology , or NGS data analysis is a plus. To apply, email your application with the reference “285E/26 DFG-Mito PhD Position” to [email protected] and [email protected] .
Articles (16)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Cockayne syndrome (CS) is a rare hereditary autosomal recessive disorder primarily caused by mutations in Cockayne syndrome protein A (CSA) or B (CSB). While many of the functions of CSB have been at least partially elucidated, little is known about the actual developmental dysregulation in this devasting disorder. Of particular interest is the regulation of cerebral development as the most debilitating symptoms are of neurological nature. We generated neurospheres and cerebral organoids utilizing Cockayne syndrome B protein (CSB)-deficient induced pluripotent stem cells derived from two patients with distinct severity levels of CS and healthy controls. The transcriptome of both developmental timepoints was explored using RNA-Seq and bioinformatic analysis to identify dysregulated biological processes common to both patients with CS in comparison to the control. CSB-deficient neurospheres displayed upregulation of the VEGFA-VEGFR2 signalling pathway, vesicle-mediated transport and head development. CSB-deficient cerebral organoids exhibited downregulation of brain development, neuron projection development and synaptic signalling. We further identified the upregulation of steroid biosynthesis as common to both timepoints, in particular the upregulation of the cholesterol biosynthesis branch. Our results provide insights into the neurodevelopmental dysregulation in patients with CS and strengthen the theory that CS is not only a neurodegenerative but also a neurodevelopmental disorder.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Collaborators (10)
James Adjaye
University Hospital Düsseldorf
Christine Margarete Freitag
W3 Professor / Director
Goethe University Frankfurt
Zacharias Kontarakis
Head of GEML
Eidgenössische Technische Hochschule Zürich
Stefan Janssen
Assistant Professor
Justus Liebig Universitat Giessen
Prigione Alessandro
Heinrich Heine University Düsseldorf
Andreas G Chiocchetti
Prof
Goethe University Frankfurt
Roel Schins
University of Maastricht
Wasco Wruck
Heinrich-Heine-Universität Düsseldorf Medizinische Fakultät
Thach Nguyen
IUF - Leibniz-Institut für umwelt- medizinische Forschung gGmbH
Jasmin Hefendehl
Professor
Goethe University Frankfurt
Make your next move.
Prepare your application
Review drafts before you send them.